Watchlist Price Alert

Nasdaq Inc. (NDAQ)

NASDAQ: NDAQ · Real-Time Price · USD

78.20

2.06 (2.71%)

At close: May 02, 2025, 3:59 PM

77.80

-0.51%

After-hours: May 02, 2025, 05:54 PM EDT

2.71% (1D)

Bid	77.8
Market Cap	44.9B
Revenue (ttm)	7.81B
Net Income (ttm)	1.28B
EPS (ttm)	2.21
PE Ratio (ttm)	35.38
Forward PE	21
Analyst	Buy

Ask	78.32
Volume	1,583,899
Avg. Volume (20D)	3,164,011
Open	76.98
Previous Close	76.14
Day's Range	76.86 - 78.34
52-Week Range	58.28 - 84.15
Beta	1.03

About NDAQ

Nasdaq, Inc. operates as a technology company that serves capital markets and other industries worldwide. The Market Technology segment includes anti financial crime technology business, which offers Nasdaq Trade Surveillance, a SaaS solution for brokers and other market participants to assist them in complying with market rules, regulations, and internal market surveillance policies; Nasdaq Automated Investigator, a cloud-deployed anti-money lau...

Sector Financial Services

IPO Date Jul 1, 2002

Employees 9,377

Stock Exchange NASDAQ

Ticker Symbol NDAQ

Website https://www.nasdaq.com

Full Company Profile

Analyst Forecast

According to 17 analyst ratings, the average rating for NDAQ stock is "Buy." The 12-month stock price forecast is $84, which is an increase of 7.42% from the latest price.

Stock Forecasts

Earnings Surprise

Nasdaq has released their quartely earnings on Apr 24, 2025:

Revenue of $1.24B exceeds estimates by $7M, with 10.74% YoY growth.

EPS of 0.79 exceeds estimates by 0.02, with 25.40% YoY growth.

Why Price Moved

3 weeks ago

-2.35%

Shares of banks and financial services companies a... Unlock content with Pro Subscription

3 weeks ago

+8.42%

Shares of banks and financial services companies are trading higher amid an overall market surge following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

News

23 hours ago · businesswire.com

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options...

1 day ago · benzinga.com

Nasdaq Surges Over 300 Points; Apple Shares Fall After Q2 Results

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 300 points on Friday.

1 day ago · fxempire.com

Nasdaq Index: Dexcom, Meta, ON Semi Lead US Stocks Rebound on Trade Optimism

Nasdaq jumps as Dexcom, Palantir, and ON Semi soar. Jobs report beats forecasts, easing inflation fears and driving US stock market optimism.

17 hours ago · accessnewswire.com

Phoenix Motor Inc. Announces Receipt of Nasdaq Listing Delinquency Letter

ANAHEIM, CA / ACCESS Newswire / May 2, 2025 / Phoenix Motor Inc. (NASDAQ:PEV) (the "Company") today announced that it received a notice (the "Notice") from the Nasdaq Listing Qualifications Department...

20 hours ago · businesswire.com

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the compensation committee of KalVista's board of directors granted three ne...

20 hours ago · businesswire.com

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for s...

22 hours ago · benzinga.com

Nasdaq Jumps 1.5% Following Strong Earnings From Meta, Microsoft: Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone

The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index moved to the “Neutral” zone on Thursday.

1 day ago · fxempire.com

Nasdaq 100: Apple, Amazon Slide After Hours as Forecasts Miss Street Expectations

Apple and Amazon dropped after hours as weak Q2 forecasts rattled traders despite strong Q1 results. Tech stocks face pressure from tariffs and cloud risks.

1 day ago · fxempire.com

Nasdaq 100: Bullish Rebound in Tech Stocks Today on Strong Microsoft, Meta Earnings

Tech stocks rally as Microsoft and Meta post strong earnings, lifting the Nasdaq 100 and boosting confidence in AI despite weak U.S. economic data.

1 day ago · fool.com

Beat the Nasdaq With This Cash-Gushing Dividend Stock

Reliable dividend income from high-quality companies is a great option for investors seeking to ride out stock market turbulence. Biotech giant Amgen (AMGN 0.82%) exemplifies this strategy with its 3....

Load More News